Report ID :10325608 |
Published Date : 21 Oct 2022 |
Report Format : |
Delivery Timeline :48-72 Business Hours
Global Pharmaceutical Contract Manufacturing Market worth USD 60.91 billion in 2016 and expected to reach USD 89.80 billion by 2022, at a CAGR of 6.7% from 2016 to 2022.
The objective of this report is to describe the market trends and revenue forecasts for the pharmaceutical contract manufacturing market for the next five years. It focuses on defining and describing the key influencing factors for the growth of the market. It also offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends. The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by the key market players. It also focuses on the key drivers, restraints, opportunities and challenges in the pharmaceutical contract manufacturing market. The scope of this report covers the pharmaceutical contract manufacturing market by its major segments which include the types, formulations, and the major geographic regions.
KEY BENEFITS OF THE REPORT
Market size and forecast estimates for all type and formulation segment for all the years from 2014 to 2022
Market estimates for four geographic and twelve regional segments
In-depth analysis of all the market dynamics that are expected to impact the market during the forecast period
Granular understanding of the historical market trend and the resultant market forecast
Deeper understanding of the behavior of the key players in the market
KEY PREMIUM INDUSTRY INSIGHTS
Rapid increase in the healthcare spending is improving access to quality healthcare, which is driving the pharmaceutical contract manufacturing market.
Rising incidences of disease like diabetes and cancer are increasing the demand for therapeutic interventions, driving the market for pharmaceutical contract manufacturing.
Rapidly aging population which is more susceptible to chronic diseases, is also one of the major growth drivers for this market.
MARKET SEGMENTATION
This report analyzes the pharmaceutical contract manufacturing market by the following segments:
Pharmaceutical Contract Manufacturing Market, by Types
Active Pharmaceutical Ingredients (APIs)
Finished Dosage Forms (FDF)
Intermediates
Pharmaceutical Contract Manufacturing Market, by Formulations
Solid Formulations
Tablets
Capsules
Powders
Semi-solid Formulations
Ointments
Gels
Other Semi-solid Formulations
Liquid Formulations
Syrups
Suspension
Other Liquid Formulations
KEY MARKET PLAYERS
Key players in the pharmaceutical contract manufacturing market include:
Aenova Holding GmbH
Baxter
Boehringer Ingelheim GmbH
Catalent, Inc.
Hospira
Jubilant Life Sciences Ltd.
Patheron
Recipharm AB
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
